B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan
نویسندگان
چکیده
منابع مشابه
Natriuretic Peptide Type-B Gene
The structure of the mouse natriuretic peptide type-B (BNP) gene was determined by isolating and sequencing genomic clones. The mouse BNP gene was structurally similar to other natriuretic peptide genes and comprised three exons and two introns. Expression of the mouse BNP gene was found only in cardiac tissue as determined by ribonuclease protection analyses. Initiation of transcription was 31...
متن کاملIncreases in B-type natriuretic peptide (BNP) during treatment with lenalidomide in AL amyloidosis.
The combination of lenalidomide and dexamethasone can produce hematologic responses in previously treated patients with AL amyloidosis.1 Since this prospective study (ClinicalTrials.gov: NCT00091260) was initiated, NT-proBNP and BNP have been found to be useful biomarkers for cardiac involvement, prognosis, and response to therapy in patients with AL amyloidosis.2-5 Here we report on the retros...
متن کاملB-type natriuretic peptide-guided treatment for heart failure
BACKGROUND Heart failure is a condition in which the heart does not pump enough blood to meet all the needs of the body. Symptoms of heart failure include breathlessness, fatigue and fluid retention. Outcomes for patients with heart failure are highly variable; however on average, these patients have a poor prognosis. Prognosis can be improved with early diagnosis and appropriate use of medical...
متن کاملBiomarker for Cardiomyopathy-B-Type Natriuretic Peptide
Cardiomyopathy is cardiac condition in which the normal muscular function of the myocardium has been altered by a variety of etiologies. Atherosclerotic coronary artery disease is the most common cause of cardiomyopathy in North America and Europe. Idiopathic cardiomyopathy is the second most common cause, although this may partially include undiagnosed etiologies such as viral infection, drug ...
متن کاملB-type natriuretic peptide: where are we?
who presented at an A&E department with acute dyspnea and showed that a BNP > 100 pg/mL had a sensitivity of 90% and a specificity of 70% in differentiating dyspnea of cardiac origin from that of other causes. The diagnostic accuracy rose from 74 to 81% when BNP levels were added to clinical criteria7. The diagnostic power of BNP was greater than that of either the Framingham criteria or the Na...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2019
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2019.01.018